Peptides are everywhere right now, but which ones actually move the needle and which ones are just expensive hype?
On this episode I break down firsthand experience with BPC-157, 5-Amino, GLP-1s, and the compounds his wife is using, separating what feels real from what sounds good in a marketing post. We get brutally honest about what happened when I tried BPC-157 for tendon pain, why 5-Amino didn’t deliver the body-composition change I wanted, and why GLP-1s may be the first “peptide” conversation that deserves real attention. If you’re trying to lose weight, preserve muscle, fight afternoon fatigue, or just make sense of the supplement-to-peptide explosion, this episode gives you a practical, no-BS filter. I unpack:
- Why Ozempic and Wegovy changed the entire peptide conversation
- The difference between one-trick GLP-1s and newer multi-pathway compounds like Retatrutide
- Why BPC-157 has a huge testimonial economy but very little human trial support
- What my wife reports from GHK-Cu, KPV, and NAD
- Why tracking calories, hydration, training, and discipline still matter, even with peptides
I also explain the trap of mistaking “I used it and felt better” for proof, and why placebo, lifestyle changes, and timing can make a compound look far more effective than it really is. At the same time, I make the case that some therapies deserve a closer look, especially when they’re backed by phase 3 data and real-world results. If you’ve been wondering whether peptides are a breakthrough tool or just the newest wellness cash grab, this episode will help you sort signal from noise. Perfect for anyone chasing fat loss, better recovery, or a clearer opinion on the compounds flooding your feed.
More episodes from "Shift Change"
Don't miss an episode of “Shift Change” and subscribe to it in the GetPodcast app.
